Brief: Propanc Biopharma To File Cta In Australia For Phase 1B Study In 30–40 Advanced Cancer Patients
20/05/2026 13:53
May 20 (Reuters) - Propanc Biopharma Inc PPCB.O: PROPANC BIOPHARMA INC - TO FILE CTA IN AUSTRALIA FOR PHASE 1B STUDY IN 30–40 ADVANCED CANCER PATIENTS PROPANC BIOPHARMA INC - PLANS TWO PHASE 2 STUDIES IN PANCREATIC AND OVARIAN CANCERS WITH 60 PATIENTS EACH Source text: ID:nGNX1HlZwj Further company coverage: PPCB.O ((Reuters.Briefs@thomsonreuters.com;))